Clinical trials

Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

Multiple locations

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Multiple locations

A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBU's) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.

Multiple locations

Phase I/II Trial of Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma

The high-grade malignant brain tumors, glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA), comprise the majority of all primary brain tumors in adults...

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075

Prospective Survey Study of Bone Health and Adherence to Osteoporosis Management in Patients with Early Stage Breast Cancer on Adjuvant Endocrine Therapy with Aromatase Inhibitors

Staten Island University Hospital | 475 Seaview Ave | Staten Island | NY 10305

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing

This phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who have undergone surgery...

Multiple locations

A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL

This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia...

Multiple locations

Phase II Trial of Super-selective Intra-arterial repeated infusion of Cetuximab for the treatment of Newly Diagnosed Glioblastoma

Primary brain cancer kills up to 10,000 Americans a year. These brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either individually or in combination...

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075

Phase I/II Study of Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed Glioblastoma (GBM)

The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your monthly regimen of oral temozolomide for the treatment of your newly diagnosed glioblastoma multiforme (GBM)...

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075

Tissue Donation for Modeling Efficacy and Toxicity of Novel Therapeutic Modalities for Brain Tumors

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075

Clinical trials : cancer-adult

Employees